Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia

@article{Yamashita2012InhibitionOH,
  title={Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia},
  author={Atsuya Yamashita and Kazi Abdus Salam and Atsushi Furuta and Yasuyoshi Matsuda and Osamu Fujita and Hidenori Tani and Yoshihisa Fujita and Yuusuke Fujimoto and Masanori Ikeda and Nobuyuki Kato and Naoya Sakamoto and Shinya Maekawa and Nobuyuki Enomoto and Masamichi Nakakoshi and Masayoshi Tsubuki and Yuji Sekiguchi and Satoshi Tsuneda and Nobuyoshi Akimitsu and Naohiro Noda and Junichi Tanaka and Kohji Moriishi},
  journal={Marine Drugs},
  year={2012},
  volume={10},
  pages={744 - 761}
}
Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest… 

Figures and Tables from this paper

Inhibition of Both Protease and Helicase Activities of Hepatitis C Virus NS3 by an Ethyl Acetate Extract of Marine Sponge Amphimedon sp

Results suggest that the novel compound(s) included in Amphimedon sp.

Identification and Analysis of Novel Inhibitors against NS3 Helicase and NS5B RNA-Dependent RNA Polymerase from Hepatitis C Virus 1b (Con1)

All inhibitors reported in this study were originally discovered with HCV anti-non-structural protein activities in vitro, highlighting how identifying new uses for existing drugs is an effective method for discovering novel HCV inhibitors.

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients

Cl cloning and expression of HCV NS3 helicase fragment in Escherichia coli BL21 (DE3) using pET102/D-TOPO expression vector and studying immunoreactivity of the expressed antigen in Iranian infected with hepatitis C seems to be a useful source of antigen for future studies on HCV diagnosis and therapy.

A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism.

A helicase assay based on fluorescence resonance energy transfer (FRET) that can be used for high-throughput screening of HCV NS3 helicase inhibitors and radioactive assays to directly visualize RNA strands unwound by helicase and to evaluate the ATPase and RNA-binding activities of NS3, which are linked to helicase activity, for characterization of the inhibitory mechanism.

Optimization of Polysaccharide Purifi cation from Microalgae BTM 11 as RNA Helicase Hepatitis C Virus Inhibitor

Results obtained from high performance liquid chromatography (HPLC) showed three peaks compounds as that the fractions of inhibitor polysaccharide are still needed to be purifi ed further, but the results obtained from thin layer chromatography showed one spot of the active compound.

Inhibitory Effects of Caffeic Acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus

Caffeic acid n-octyl ester could synergistically enhance the anti-HCV activities of interferon-alpha 2b, daclatasvir, and VX-222, but neither telaprevir nor danoprevir is a potential candidate for novel anti- HCV chemotherapy drugs.

Prokaryotic Expression of Hepatitis C Virus-NS3 Protein and Preparation of a Monoclonal Antibody.

To build a more reliable diagnostic method for HCV, gene fragments of HCV-NS3 linked to a carrier, pET28a, are expressed and this vector is transformed into Escherichia E. coli.

Recent advancement in small molecules as HCV inhibitors.

Natural products for the management of the hepatitis C virus: a biochemical review

The current state of knowledge on natural products and their possible activities in the context of HCV infection will be summarised, and many phytochemical constituents have been identified that display considerable inhibition ofHCV at some stage of the life cycle.

Hepatitis C Virus NS3 Inhibitors: Current and Future Perspectives

This review article summarizes the current understanding of HCV treatment, particularly with those of NS3 inhibitors, and focuses on the helicase portion of the HCV NS3 protein.

References

SHOWING 1-10 OF 48 REFERENCES

Effect of Alpha Interferon on the Hepatitis C Virus Replicon

A subgenomic replicon is constructed from a known infectious HCV clone and it is demonstrated that it has an approximately 1,000-fold-higher transduction efficiency than previously used subgenomes and was sensitive to IFN-α independently of whether the replicon expressed an NS5A protein associated with sensitivity or resistance to the cytokine.

Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.

A thorough molecular modeling study was carried out to explain the molecular basis of NS3h inhibition by QU663, one of a new generation of small-molecule nucleotide-mimicking inhibitors which are potential anti-HCV agents.

Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA*

Purified proanthocyanidin showed dose-dependent inhibition of expression of the neomycin-resistant gene and the NS-3 protein gene in the HCV subgenome in replicon cells, and heterogeneous nuclear ribonucleoprotein A2/B1 showed affinity to blueberry leaf-derived proanthongenidin and was indispensable for HCVSubgenome expression in replicons cells.

Multiple effects of silymarin on the hepatitis C virus lifecycle

Although inhibition of in vitro NS5B polymerase activity is demonstrable, the mechanisms of silymarin's antiviral action appear to include blocking of virus entry and transmission, possibly by targeting the host cell.

Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C.

Unique features of the HCV helicase, recently discovered compounds that inhibit HCV Helicase catalyzed reactions and HCV cellular replication, and new methods to monitor helicase action in a high-throughput format are discussed.

Host factors involved in the replication of hepatitis C virus

This review considers the current knowledge of the host proteins that participate in HCV replication and the possibility of developing novel therapeutics intervention for chronic hepatitis C.

Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

The results of this study provide a basis for the optimization and subsequent development of members of the Flavonoid family as specific HCV antivirals.

The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

  • D. Frick
  • Biology
    Current issues in molecular biology
  • 2007
Compounds recently reported to inhibit HCV helicase will be useful for elucidating the role of a helicase in positive-sense single-stranded RNA virus replication and might serve as templates for the design of novel antiviral drugs.

Inhibition of intracellular hepatitis C virus replication by synthetic and vector‐derived small interfering RNAs

The results support the feasibility of using siRNA‐based gene therapy to inhibit HCV replication, which may prove to be valuable in the treatment of hepatitis C.